Triple
T2790852
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Daphne Koller |
E61924
|
entity |
| Predicate | coFounded |
P104
|
FINISHED |
| Object |
Insitro
Insitro is a biotechnology company that uses machine learning and high-throughput biology to accelerate drug discovery and development.
|
E298582
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Insitro | Statement: [Daphne Koller, coFounded, Insitro]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Insitro Context triple: [Daphne Koller, coFounded, Insitro]
-
A.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a leading American biotechnology company known for developing innovative antibody-based therapies for serious diseases, including eye disorders, cancer, and inflammatory conditions.
-
B.
Verily Life Sciences LLC
Verily Life Sciences LLC is a health-focused research and technology company that develops tools and platforms to collect, organize, and analyze health data, particularly in areas like clinical research, precision health, and disease management.
-
C.
BioNTech
BioNTech is a German biotechnology company best known for developing one of the first mRNA-based COVID-19 vaccines in partnership with Pfizer.
-
D.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company specializing in the development of RNA interference (RNAi)-based therapeutics for genetically defined diseases.
-
E.
Genmab
Genmab is a Danish biotechnology company specializing in the development of antibody-based cancer therapies.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Insitro Triple: [Daphne Koller, coFounded, Insitro]
Generated description
Insitro is a biotechnology company that uses machine learning and high-throughput biology to accelerate drug discovery and development.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Insitro Target entity description: Insitro is a biotechnology company that uses machine learning and high-throughput biology to accelerate drug discovery and development.
-
A.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a leading American biotechnology company known for developing innovative antibody-based therapies for serious diseases, including eye disorders, cancer, and inflammatory conditions.
-
B.
Verily Life Sciences LLC
Verily Life Sciences LLC is a health-focused research and technology company that develops tools and platforms to collect, organize, and analyze health data, particularly in areas like clinical research, precision health, and disease management.
-
C.
BioNTech
BioNTech is a German biotechnology company best known for developing one of the first mRNA-based COVID-19 vaccines in partnership with Pfizer.
-
D.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company specializing in the development of RNA interference (RNAi)-based therapeutics for genetically defined diseases.
-
E.
Genmab
Genmab is a Danish biotechnology company specializing in the development of antibody-based cancer therapies.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69ab4b7f51d881908768300ebd2fbdae |
completed | March 6, 2026, 9:47 p.m. |
| NER | Named-entity recognition | batch_69abddcfe19c81908f94dd449f18a2c2 |
completed | March 7, 2026, 8:12 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69afc65c1f848190b6efeefb64a3e131 |
completed | March 10, 2026, 7:21 a.m. |
| NEDg | Description generation | batch_69afc6e6d4bc81908108fe24677448c3 |
completed | March 10, 2026, 7:23 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69afc7907be88190b70458ed735261e8 |
completed | March 10, 2026, 7:26 a.m. |
Created at: March 6, 2026, 9:58 p.m.